Proteomic Analysis of Anti‐inflammatory Effects of a Kampo (Japanese Herbal) Medicine “Shoseiryuto (Xiao‐Qing‐Long‐Tang)” on Airway Inflammation in a Mouse Model
Open Access
- 1 January 2011
- journal article
- research article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2011 (1) , 1-13
Abstract
Effects of a Kampo (Japanese herbal) medicine “shoseiryuto (SST, xiao‐qing‐long‐tang in Chinese)”, which has been used for the treatment of allergic bronchial asthma clinically, were examined on ovalbumin (OVA)‐sensitized allergic airway inflammation model (i.e., bronchial asthma) in a mouse. When SST was orally administered at 0.5 g kg−1 day−1 from day 1 to 6 after OVA inhalation, SST reduced the inflammation in lung tissue, the number of eosinophils and the OVA‐specific immunoglobulin E (IgE) antibody titer in bronchoalveolar lavage (BAL) fluids at 7 days after the OVA inhalation. SST also reduced the airway hyperreactivity at 6 days after the OVA inhalation. Proteomic analysis with the agarose two‐dimensional electrophoresis showed that the expression of spectrin α2 was reduced in the lung tissue of OVA‐sensitized mice and SST recovered the expression. Western blot and immunohistochemical analyses of lung tissue also confirmed this result. When prednisolone was orally administered at 3 mg kg−1 day−1 from day 1 to 6 after OVA inhalation, the inflammation in lung tissue, the number of eosinophils in BAL fluids and airway hyperreactivity were reduced in the OVA‐sensitized mice. However, prednisolone did not reduce the OVA‐specific IgE antibody titer in BAL fluids and did not recover the expression of spectrin α2 in lung tissue. These results suggest that at least a part of action mechanism of SST against OVA‐sensitized allergic airway inflammation in a mouse model is different from that of prednisolone.Keywords
Funding Information
- Japan Society for the Promotion of Science (17590601)
This publication has 38 references indexed in Scilit:
- The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part IEvidence-Based Complementary and Alternative Medicine, 2011
- Pharmacogenetics of asthmaCurrent Opinion in Pulmonary Medicine, 2009
- Review: Omalizumab in the treatment of severe asthma: efficacy and current problemsTherapeutic Advances in Respiratory Disease, 2008
- Gene transfer of PEDF attenuates ischemic brain damage in the rat middle cerebral artery occlusion modelJournal of Neurochemistry, 2008
- Regulatory T Cells, a Potent Immunoregulatory Target for CAM Researchers: Modulating Allergic and Infectious Disease Pathology (II)Evidence-Based Complementary and Alternative Medicine, 2006
- AsthmaNew England Journal of Medicine, 2001
- Effects of Sho-seiry-to on experimental allergic rhinitis in guinea pigsMethods and Findings in Experimental and Clinical Pharmacology, 1999
- In VivoAnti-Influenza Virus Activity of Kampo (Japanese Herbal) Medicine “Sho-Seiryu-To”—Stimulation of Mucosal Immune System and Effect on Allergic Pulmonary Inflammation Model MiceImmunopharmacology and Immunotoxicology, 1998
- Mechanisms of allergic pulmonary eosinophilia in the mouseJournal of Allergy and Clinical Immunology, 1994
- Aerosolized antigen exposure without adjuvant causes increased IgE production and increased airway responsiveness in the mouseJournal of Allergy and Clinical Immunology, 1992